STAT Plus: Biotech in the time of the coronavirus: With China returning to work, preclinical companies ramping back up
In this edition: Chinese labs returning to work; a look at prescription drug data; more corporate updates; and another super-cute dog pic.
No hay comentarios:
Publicar un comentario